Hutchison China MediTech Ltd ADR Stock
Our community is currently high on Hutchison China MediTech Ltd ADR with 3 Buy predictions and 1 Sell predictions.
With a target price of 17 € there is a hugely positive potential of 54.55% for Hutchison China MediTech Ltd ADR compared to the current price of 11.0 €.
Pros and Cons of Hutchison China MediTech Ltd ADR in the next few years
Pros
?
C******** o* t** e**********
?
M***** P*******
?
S********** s********
Cons
?
B****
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Hutchison China MediTech Ltd ADR vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Hutchison China MediTech Ltd ADR | - | -0.901% | -7.563% | -18.519% | -17.910% | -19.118% | -52.991% |
| China Resources Pharmaceutical Group Ltd | 0.410% | 0.830% | -5.631% | -26.364% | -28.000% | -36.053% | 21.500% |
| China Traditional Chinese Medicine Co Ltd | -0.890% | 0.000% | -9.016% | -17.164% | -18.382% | -49.545% | -40.957% |
| Repligen Corp. | -1.530% | 2.541% | -2.720% | 0.929% | 0.929% | -10.397% | -12.485% |
Comments
HUTCHMED (NASDAQ:HCM) was upgraded by analysts at Wall Street Zen from a "hold" rating to a "buy" rating.
Show more
Ratings data for HCM provided by MarketBeat
HUTCHMED (NASDAQ:HCM) was downgraded by analysts at Morgan Stanley from an "equal weight" rating to an "underweight" rating. They now have a $13.75 price target on the stock.
Show more
Ratings data for HCM provided by MarketBeat
HUTCHMED (China) Limited Sponsored ADR (NASDAQ: HCM) had its price target raised by analysts at Bank of America Corporation from $27.00 to $28.00. They now have a "buy" rating on the stock.
Show more
Ratings data for HCM provided by MarketBeat